A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

BACKGROUND: Platinum-based combinations are the standard second-line treatment for platinum-sensitive ovarian cancer (OC). This randomized phase II study was undertaken in order to compare the combination of carboplatin and pegylated liposomal doxorubicin (LD) with carboplatin and paclitaxel (CP) in...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Bafaloukos, Dimitrios, Linardou, Helena, Aravantinos, Gerasimos, Papadimitriou, Christos, Bamias, Aristotelis, Fountzilas, George, Kalofonos, Haralabos P, Kosmidis, Paris, Timotheadou, Eleni, Makatsoris, Thomas, Samantas, Epaminondas, Briasoulis, Evangelos, Christodoulou, Christos, Papakostas, Pavlos, Pectasides, Dimitrios, Dimopoulos, Athanasios M
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2010
विषय:
Research article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2823653/
https://ncbi.nlm.nih.gov/pubmed/20055981
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7015-8-3
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन